Altium Capital Management LP 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 3:47 pm Unchanged | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LP | 809 4.990% | 0 (Unchanged) | Filing |
| 2024-01-10 1:35 pm Purchase | 2023-12-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LP | 809 8.000% | 809 (New Position) | Filing |